Zearalenone promotes hepatic lipid accumulation via EGFR-HSP90 complex stabilization.
Zearalenone (ZEA), a widespread foodborne mycotoxin, has been implicated in metabolic dysfunction-associated fatty liver disease (MAFLD), although its direct hepatic targets and mechanisms remain unclear. This study aimed to identify the molecular target of ZEA and elucidate its role in hepatic lipid dysregulation. Usi...